Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Alzheimer's Disease

Free Subscription 22.12.2025 13 Alzheimers Dement 1 Am J Geriatr Psychiatry 1 BMC Neurol 1 Brain 1 Curr Alzheimer Res 4 J Alzheimers Dis 1 J Am Geriatr Soc 2 J Neurol 3 JAMA 1 Nat Neurosci 3 Nature 1 Neurology 5 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. LORENZ LMC, Rohde SK, Luimes MC, Rozemuller AJM, et al
   AD-related plasma biomarkers in centenarians: links to cognition and neuropathology.
   Alzheimers Dement. 2025;21:e70969.
   PubMed         Abstract available
   
   
2. WALTER S, Ptomey L, Head E, Cohen A, et al
   "Being brave, being seen, and having your voice heard": Perspectives of self-advocates and families toward accessible and impactful research of Alzheimer's disease in down syndrome.
   Alzheimers Dement. 2025;21:e70999.
   PubMed         Abstract available
   
   
3. TABLANTE J, Casaletto K, VandeVrede L, Mamuyac E, et al
   The role of bilingualism on functional decline and neurodegeneration in distinct ADRD clinical syndromes.
   Alzheimers Dement. 2025;21:e70991.
   PubMed         Abstract available
   
   
4. JANVE VA, Seto M, Sperling RA, Aisen PS, et al
   Blood gene expression network expression strongly relates to brain amyloid burden.
   Alzheimers Dement. 2025;21:e70982.
   PubMed         Abstract available
   
   
5. KRANZ DL, de Leon Velez O, Ulupinar E, Ozdinler PH, et al
   Identification of a glia-associated amyloid beta oligomer subtype and the rescue from reactive astrogliosis by inhibitor NU-9.
   Alzheimers Dement. 2025;21:e70968.
   PubMed         Abstract available
   
   
6. THOMPSON LI, Gaster B, Hammers DB, Fittipaldi S, et al
   Acceptable standards for clinic-based digital cognitive assessments: Recommendations from the Global CEO Initiative on Alzheimer's Disease.
   Alzheimers Dement. 2025;21:e70966.
   PubMed         Abstract available
   
   
7. CUSTODIO N, Brown G, Custodio B, Montesinos R, et al
   Functional capacity in Peruvian people with Alzheimer's disease and frontotemporal dementia.
   Alzheimers Dement. 2025;21:e70979.
   PubMed         Abstract available
   
   
8. ZHANG B, McEvoy LK, Nguyen S, Espeland MA, et al
   Epigenetic clocks and longitudinal plasma biomarkers of Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70983.
   PubMed         Abstract available
   
   
9. TABRIZI Z, Lim XR, Chakraborty S, Harraz OF, et al
   Systemic Piezo1 activation improves cerebrovascular function in Alzheimer's disease.
   Alzheimers Dement. 2025;21:e71016.
   PubMed         Abstract available
   
   
10. DI DONNA MG, Motta C, Bonomi CG, Bernocchi F, et al
    Reframing TDP-43 in Alzheimer's disease: From co-pathology to neurovascular culprit.
    Alzheimers Dement. 2025;21:e70988.
    PubMed         Abstract available
    
    
11. NJAMNSHI WY, Chiotis K, Tsoy E, Blazhenets G, et al
    Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease.
    Alzheimers Dement. 2025;21:e71012.
    PubMed         Abstract available
    
    
12. KANG KM, Park C, Nam H, Byun MS, et al
    Intracranial stenosis and longitudinal progression of Alzheimer's disease pathologies.
    Alzheimers Dement. 2025;21:e71010.
    PubMed         Abstract available
    
    
13. LIU Y, Zhu H, Wang Y, Luan X, et al
    Apolipoprotein E epsilon4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: A mediation analysis of vascular contributions to cognitive decline.
    Alzheimers Dement. 2025;21:e71000.
    PubMed         Abstract available
    
    

    
    Am J Geriatr Psychiatry

14. SAHA S, Spalzang S, Padhy SK, Parmar A, et al
    Reflections on a Study of Low-Dose Agomelatine as Add-on for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2025 Nov 22:S1064-7481(25)00531.
    PubMed        
    
    

    
    BMC Neurol

15. ZHANG HE, Xiao ML, Ji JJ, Cheng YR, et al
    Integrating machine learning and experiments to elucidate the potential molecular mechanisms of methylparaben-induced Alzheimer's disease: evidence from a Tau hyperphosphorylation cell model.
    BMC Neurol. 2025 Dec 18. doi: 10.1186/s12883-025-04582.
    PubMed         Abstract available
    
    

    
    Brain

16. ZU J, Li C, Cui M, Liu X, et al
    Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer's disease model.
    Brain. 2025 Dec 15:awaf462. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

17. HOSSEINI SF, Akbarabadi P, Noorani F, Kazemi D, et al
    Association of Brain and Ventricular Boundary Shift Integral Measurements with CSF Biomarkers: A Case-Control Study.
    Curr Alzheimer Res. 2025;22:359-367.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

18. LENG L, Liao Z, Lu P, Sun Y, et al
    Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China.
    J Alzheimers Dis. 2025 Dec 15:13872877251406619. doi: 10.1177/13872877251406619.
    PubMed         Abstract available
    
    
19. BOCCARDI V
    From risk to prevention: Clinical and public health strategies to reduce Alzheimer's disease burden.
    J Alzheimers Dis. 2025 Dec 16:13872877251407715. doi: 10.1177/13872877251407715.
    PubMed         Abstract available
    
    
20. MUTHURAMALINGAM K, Lee HJ
    Carbon nanomaterials for tau targeting in Alzheimer's disease: Theranostic strategies and clinical prospects.
    J Alzheimers Dis. 2025 Dec 19:13872877251407702. doi: 10.1177/13872877251407702.
    PubMed         Abstract available
    
    
21. YOKOI T
    Need for analysis of linguistic factors for elucidating the pathogenesis of Alzheimer's disease: A position paper.
    J Alzheimers Dis. 2025 Dec 19:13872877251407350. doi: 10.1177/13872877251407350.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

22. GHAHREMANI M, Smith EE, Ismail Z
    Persistent Functional Impairment as an Early Indicator of Alzheimer Disease Pathology and Progression.
    J Am Geriatr Soc. 2025 Dec 15. doi: 10.1111/jgs.70247.
    PubMed         Abstract available
    
    

    
    J Neurol

23. DUAN X, Wang F, Liu W, Xie Y, et al
    The diagnostic value of plasma Abeta42 and Abeta40 in Alzheimer's disease: current status, challenges, and impacting variables.
    J Neurol. 2025;273:30.
    PubMed         Abstract available
    
    
24. GUILLEN N, Esteller D, Sarto J, Perales I, et al
    Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.
    J Neurol. 2025;273:28.
    PubMed         Abstract available
    
    

    
    JAMA

25. KNOPMAN DS
    Valacyclovir and Symptomatic Alzheimer Disease-No Evidence for Benefit.
    JAMA. 2025 Dec 17. doi: 10.1001/jama.2025.20795.
    PubMed        
    
    
26. 
    Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: Research Summary.
    JAMA. 2025 Dec 17:e2522830. doi: 10.1001/jama.2025.22830.
    PubMed        
    
    
27. DEVANAND DP, Wisniewski T, Razlighi Q, Qian M, et al
    Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.
    JAMA. 2025 Dec 17:e2521738. doi: 10.1001/jama.2025.21738.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

28. GREEN NFO, Sutton GJ, Perez-Burillo J, Wang J, et al
    CRISPRi screening in cultured human astrocytes uncovers distal enhancers controlling genes dysregulated in Alzheimer's disease.
    Nat Neurosci. 2025 Dec 18. doi: 10.1038/s41593-025-02154.
    PubMed         Abstract available
    
    

    
    Nature

29. CASAMITJANA A, Mancini M, Robinson E, Peter L, et al
    A probabilistic histological atlas of the human brain for MRI segmentation.
    Nature. 2025;648:678-685.
    PubMed         Abstract available
    
    
30. AARSLAND D, Sunde AL, Tovar-Rios DA, Leuzy A, et al
    Prevalence of Alzheimer's disease pathology in the community.
    Nature. 2025 Dec 17. doi: 10.1038/s41586-025-09841.
    PubMed         Abstract available
    
    
31. MULLARD A
    How common is Alzheimer's? Blood-test study holds surprises.
    Nature. 2025 Dec 17. doi: 10.1038/d41586-025-04133.
    PubMed        
    
    

    
    Neurology

32. DU Y, Borne Y, Samuelsson J, Glans I, et al
    High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study.
    Neurology. 2026;106:e214343.
    PubMed         Abstract available
    
    

    
    Neuroscience

33. IOANNIDOU E, Vavilis T, Bourtzos Z, Stamoula E, et al
    Corrigendum to "A review of the TGF-beta1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants" [Neuroscience 585 (2025) 429-440].
    Neuroscience. 2025;593:170.
    PubMed        
    
    
34. MEHMOOD A, Shahid F, Khan R, AlZu'bi H, et al
    A review of deep learning techniques in Alzheimer's disease with emphasis on data tools and transfer learning.
    Neuroscience. 2025;593:242-254.
    PubMed         Abstract available
    
    
35. JOGESHWAR BK, Lu S, Nephew BC
    Neuroanatomical-based machine learning prediction of Alzheimer's Disease across sex and age.
    Neuroscience. 2025 Dec 14:S0306-4522(25)01177.
    PubMed         Abstract available
    
    
36. ZHOU W, Qu R, Luo W, Zhang H, et al
    Identification of cognitive brain diseases using a dual-branch siamese network on structural magnetic resonance imaging data.
    Neuroscience. 2025;591:83-92.
    PubMed         Abstract available
    
    
37. HU K, Li C, Liu Y, Pan C, et al
    Arabinoxylan ameliorates memory deficits and amyloid pathology in male 5 x FAD mice via modulation of gut microbiota structure.
    Neuroscience. 2025;591:52-62.
    PubMed         Abstract available
    
    

    
    PLoS One

38. TANJIN R, Al-Amin M, Etee JM, Siddika A, et al
    An evaluation of Roluperidone as a promising repurposing candidate for Alzheimer's Disease: A Computational Investigation.
    PLoS One. 2025;20:e0338211.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.